“The literature is nearly unanimous in suggesting that cannabinoids and endocannabinoids reduce the progression of cancer in preclinical model systems.” ~ Cancer and Metastasis Review, Oct. 2011
THC and CBD may slow down or even stop the growth of cancer cells in brain, lung, breast, liver and skin.
A link between brain cancer (glioblastoma) and cannabinoid receptors has been known since 2001.
Growth of malignant melanoma cells have been linked to anandamide since 2013.
A connection between Hodgkin’s Lymphoma and cannabinoid receptors was discovered in 2013.
Cannabis-like compounds offer therapeutic potential for the treatment of breast, prostate and bone cancer in patients.” ~British Journal of Pharmacology, 2011
Breast cancer cells were found to contain cannabinoid receptors in 2006.
In stage IV colorectal cancer, the level of cannabinoid receptors was found to be a factor in a bad prognosis following surgery.
In pancreatic tumors, higher volumes of cannabinoid receptors were shown in patients with shorter survival time (median 6 months)
.Ovarian and prostate tumours have been found high in cannabinoid receptors.
Cannabis-like compounds offer therapeutic potential for the treatment of breast, prostate and bone cancer in patients.” ~British Journal of Pharmacology, 2011
1 Comment